Annovis Bio, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
46.00
|
|
Average Rating
|
4.33
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.90
|
0.00
|
0.90
|
100.00%
|
|
2022-12-31
|
-1.00
|
0.00
|
1.00
|
100.00%
|
|
2022-09-30
|
-1.01
|
-0.93
|
0.08
|
7.92%
|
|
2022-06-30
|
-0.64
|
-1.07
|
-0.43
|
-67.19%
|
|
2022-03-31
|
-0.58
|
-0.72
|
-0.14
|
-24.14%
|
|
2021-12-31
|
-0.25
|
-0.75
|
-0.50
|
-200.00%
|
|
2021-09-30
|
-0.44
|
-0.35
|
0.09
|
20.45%
|
|
2021-06-30
|
-0.37
|
-0.34
|
0.03
|
8.11%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.72
|
|
2021-12-31
|
-1.90
|
|
2020-12-31
|
-0.84
|
|
2019-12-31
|
-0.10
|